Editorial Staff

Valuing Life-Saving Drugs: What is the Price of Life and Who Decides?

/in , , , /by Editorial Staff
Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Hubwonk host Joe Selvaggi talks with Pioneer Institute visiting fellow Dr. Bill Smith about Quality Adjusted Life Years (QALY) standards, and the ways in which so-called objective cost-containing strategies use expert opinion to determine the value of a life and thereby disadvantage the elderly, disabled, and those with less common vulnerabilities to disease.

Guest:

William S. Smith is Visiting Fellow in Life Sciences at Pioneer Institute. He has 25 years of experience in government and in corporate roles, including as vice president of public affairs and policy at Pfizer, and as a consultant to major pharmaceutical, biotechnology and medical device companies. He held senior staff positions for the Republican House leadership on Capitol Hill, the White House, and in the Massachusetts Governor’s office. He is affiliated as research fellow and managing director with the Center for the Study of Statesmanship at The Catholic University of America (CUA), where he earned his PhD.

Related research: Analysis: ICER Framework Ignores Patient Preferences, Innovation & Societal Benefits in Evaluating Cost-Effectiveness of New Cancer Treatments

Get new episodes of Hubwonk in your inbox!

Related Posts:

Voting for Health: Party Opinions, Election Results & the Healthcare Policy Implications of Election 2020

0 Comments
/
Join Host Joe Selvaggi as he discusses with Harvard Professor Bob Blendon his New England Journal of Medicine Special Report, "Implications of the 2020 Election for U.S. Health Policy," which covers broad differences in both party’s view of the role of government in health care and what the election results will mean for Americans.

Staving Off Disaster: Lessons from Covid Applied to the Epic Battle Against Drug Resistant Microbes

0 Comments
/
Join Hubwonk host Joe Selvaggi and Pioneer Institute’s Bill Smith as they discuss with inspirational public health advocate Gunnar Esiason the findings of his latest white paper, "Antimicrobial Resistance: Learning From the current health crisis to inform another."  The episode looks at the challenges to global health presented by evolving drug resistant diseases and how the lessons learned from COVID-19 could potentially save millions of lives.

Study: Growth of Antibiotic-Resistant Infections Could Have Massive Human, Financial Costs

The world was blindsided by COVID-19, but a new Pioneer Institute study finds that even as we continue to wrestle with the pandemic, another threat looms that scientists have long known about but the nation has thus far failed to address: the growth of antibiotic-resistant infections. “Market dysfunction and perverse Medicare reimbursement rates have led to a growth in infections that resist antibiotics,” said Gunnar Esiason, author of “Antimicrobial Resistance: Learning from the current global health crisis to prevent another one.”  If we don’t solve this problem, the human and economic costs are likely to be astronomical.”

Clearing Boston’s Throat: What the I-90 Allston Project Portends for Metro West Commuters

0 Comments
/
Join hosts Joe Selvaggi and Pioneer Institute’s Mary Connaughton, and guest, former Mass. Secretary of Transportation Jim Aloisi, as they discuss the I90 Allston Multimodal Project, its long-term benefits, and their concerns for the metro west commuters and communities during the project’s decade-long construction.

Ballot Question 1: Risks & Regulations Regarding Right to Repair

0 Comments
/
Join host Joe Selvaggi and security technologist Prof. Bruce Schneier as they discuss risks associated with car telematics as well as how best to ensure public safety in the future of the internet of everything.

Small Business Life Support: Policy Relief for Firms Sickened by COVID?

0 Comments
/
Host Joe Selvaggi talks with Pioneer Institute’s Andrew Mikula and Retailers Association of Massachusetts' Jon Hurst about the state of small business in Massachusetts six months into the pandemic.

Supreme Court Vacancy: The History, the Stakes & the Options for Replacing a Justice

0 Comments
/
Hubwonk Host Joe Selvaggi talks with Cato Institute's Ilya Shapiro about his new book, Supreme Disorder: Judicial Nominations and the Politics of America's Highest Court.  The episode equips listeners with historical context to better understand the makeup of the Court, the nomination process, and the impact of a new justice on the Court.

Ranked Choice: Ballot Question 2 Redefines What a Vote and Majority Mean

0 Comments
/
Join host Joe Selvaggi as he discusses Ranked Choice Voting with former Federal Election Commissioner Lee Goodman. As a recognized national expert in election administration, Commissioner Goodman offers a deep dive on the contours of ranked choice voting, including the benefits and challenges moving to the new system would offer Massachusetts voters.

Lockdowns – Lawless or Laudable? Grading Gov. Baker’s COVID-19 Emergency Orders 6 Months On

Join Joe Selvaggi and Pioneer Institute’s executive director Jim Stergios for a conversation with Boston Globe columnist Jeff Jacoby about the lawsuit against the Massachusetts Governor’s executive orders. They will explore what can be learned from the first six months of the COVID-19 pandemic, and what must be considered when devising a new way forward.

Drug Rebates: How Pharmacy Benefit Managers Manipulate Price & Limit Choice

0 Comments
/
Join host Joe Selvaggi and his guest Dr. Bill Smith as they discuss the complex incentive structure between drug manufacturers, health plans, and pharmacy benefit managers. In this episode, they focus on how drug rebates work and how a system intended to optimize value may actually deliver higher costs and fewer choices. Joe and Bill also use this framework to speculate on the price of a COVID-19 vaccine, and who will likely pay for it.